Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30023045HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023046HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023047HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023048HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS30023049HIVENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TVIS44018658HTLV-1ENSG00000182866.18protein_codingLCKYesNo3932A0A0S2Z3Y4
A0A0S2Z3Y8
P06239
Q573B4
TCGA Plot Options
Drug Information
GeneLCK
DrugBank IDDB08901
Drug NamePonatinib
Target IDBE0000842
UniProt IDP06239
Regulation Typeinhibitor
PubMed IDs23190395
CitationsGushwa NN, Kang S, Chen J, Taunton J: Selective targeting of distinct active site nucleophiles by irreversible SRC-family kinase inhibitors. J Am Chem Soc. 2012 Dec 19;134(50):20214-7. doi: 10.1021/ja310659j. Epub 2012 Dec 4.
GroupsApproved; Investigational
Direct ClassificationBenzanilides
SMILESCN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
PathwaysPonatinib Inhibition of BCR-ABL
PharmGKBPA165980594
ChEMBLCHEMBL1171837